No abstract available
Publication types
-
Clinical Trial, Phase III
MeSH terms
-
Aged
-
Bortezomib / therapeutic use
-
Female
-
Humans
-
Male
-
Middle Aged
-
Peripheral Nervous System Diseases* / diagnosis
-
Peripheral Nervous System Diseases* / etiology
Grants and funding
Funding: This study was supported by Intergroupe Francophone du Myélome (IFM), the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) in collaboration with Janssen Research & Development and the Dutch Cancer Society (KWF).